CD44 and cancer: Immunophenotyping of CD44+/CD24− populations in naïve tumors and chemo-treated tumors from patients undergoing MRM in comparison to the normal mammary tissue showed a differential count of this subset in the cancer stem cell population with chemo-treatment augmenting their numbers (Supplemenatry Fig. 2).